Gland PharmaI'm not saying that Gland Pharma is good, but if you keep portion of the stock, you could see a significant return with a strict stop loss of 892 to 875 (Big Range).
I believe that if it crosses 952-955, it may reach 980, 1060, or 1200.
This is purely for educational purposes; it is not a recommendation, and neither am I a registered advisor with SEBI.
Don't take it personally; invest before you communicate to your advisor.
GLAND trade ideas
Gland Pharma Gland Pharma has been in a long term bearish trend, which has it's bottom around 856 and has made a morning star pattern in the weekly time frame along with a bullish RSI divergence.
A continuation green candle can act as signal for short term reversal.
It can act as a bottom picking candidate with a stop loss around all time low, providing us with a favourable risk to reward.
GLAND - Bullish view - 10% ROIAll details are given on chart. If you like the analyses please do share it with your friends, like and follow me for more such interesting charts.
Disc - Am not a SEBI registered. Please do your own analyses before taking position. This post is only for educational purposes and not a trading recommendation
Gland Pharma Investment StockEstablished in Hyderabad, India in 1978, Gland Pharma has grown over the years from a contract manufacturer of small volume liquid parenteral products, to become one of the largest and fastest growing injectable-focused companies, with a global footprint across 60 countries, including the United States, Europe, Canada, Australia, India and other markets. We operate primarily under a business to business (B2B) model and have an excellent track record in the development, manufacturing and marketing of complex injectables. This presence across the value chain has helped us witness exponential growth. We are promoted by Shanghai Fosun Pharma, a global pharmaceutical major.
Vaise company ekdam best hai and acha khaasa discount pe bhi mil rhi h,,isne 13th august ko 4287 ka high banake falling knife ban gya hai and niche he aaye ja rha h. No doubt company is good, management is good, only stock has corrected. my view is to invest for long term in it..this could be next natco pharma, in long term.
Right now it is trading at 1395, best price to enter for long term,,, if we found this stock little more down,,do average out. this is definately going to make you wealthy..
Please like and comment and tell me your views on this falling knife..And please don't forget to follow me on tradingview.com
Thankyou
GLAND PHARMA, TOUCHED ITS IPO PRICE!!after its recent quarterly results it fell a lot.
its a very good stock for the swing trade. i have mentioned its targets and they are good support for those
earlier a month ago, i had posted its 5 waves. and this time i have extended it till its IPO PRICE. its a bit sad, that it came down this low. but its good to buy in dip.
i am aiming for the targets mentioned.
do check he trend line drawn in RSI indicator too.
the stock has touched its bottom, and one can do momentum investing till the stock consolidates in the future.
GLAND PHARMA, RSI DIVERGENCE!!the stock will have a good impulse move, it has corrected a lot, one can earn about 90% from taking a swing trade. the stock has reached at a price of its IPO's time only.
good RSI DIVERGENCE is forming.
stock price targets are too mentioned.
at last: have a look on moving averages too.
Gland Pharma IndiaSun Storm Investment Trading Desk & NexGen Wealth Management Service Present's: SSITD & NexGen Portfolio of the Week Series
Focus: Worldwide
By Sun Storm Investment Research & NexGen Wealth Management Service
A Profit & Solutions Strategy & Research
Trading | Investment | Stocks | ETF | Mutual Funds | Crypto | Bonds | Options | Dividend | Futures |
USA | Canada | UK | Germany | France | Italy | Rest of Europe | Mexico | India
Disclaimer: Sun Storm Investment and NexGen are not registered financial advisors, so please do your own research before trading & investing anything. This is information is for only research purposes not for actual trading & investing decision.
#debadipb #profitsolutions